SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017204
Filing Date
2022-11-09
Accepted
2022-11-09 17:01:22
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mxct-20220930x10q.htm   iXBRL 10-Q 1601001
2 EX-31.1 mxct-20220930xex31d1.htm EX-31.1 14362
3 EX-31.2 mxct-20220930xex31d2.htm EX-31.2 13580
4 EX-32.1 mxct-20220930xex32d1.htm EX-32.1 7732
5 EX-32.2 mxct-20220930xex32d2.htm EX-32.2 7105
  Complete submission text file 0001558370-22-017204.txt   6115463

Data Files

Seq Description Document Type Size
6 EX-101.SCH mxct-20220930.xsd EX-101.SCH 36258
7 EX-101.CAL mxct-20220930_cal.xml EX-101.CAL 50461
8 EX-101.DEF mxct-20220930_def.xml EX-101.DEF 138522
9 EX-101.LAB mxct-20220930_lab.xml EX-101.LAB 383032
10 EX-101.PRE mxct-20220930_pre.xml EX-101.PRE 268487
52 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20220930x10q_htm.xml XML 1053773
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40674 | Film No.: 221373543
SIC: 8731 Services-Commercial Physical & Biological Research